- Home
- HQL vs SAR Comparison
HQL vs SAR Comparison
Compare HQL & SAR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HQL
- SAR
- Stock Information
- Founded
- HQL 1992
- SAR 2007
- Country
- HQL United States
- SAR United States
- Employees
- HQL N/A
- SAR N/A
- Industry
- HQL Investment Managers
- SAR Investment Managers
- Sector
- HQL Finance
- SAR Finance
- Exchange
- HQL Nasdaq
- SAR Nasdaq
- Market Cap
- HQL 368.7M
- SAR 337.6M
- IPO Year
- HQL N/A
- SAR 2007
- Fundamental
- Price
- HQL $11.98
- SAR $23.43
- Analyst Decision
- HQL
- SAR Buy
- Analyst Count
- HQL 0
- SAR 4
- Target Price
- HQL N/A
- SAR $25.08
- AVG Volume (30 Days)
- HQL 120.9K
- SAR 90.2K
- Earning Date
- HQL 01-01-0001
- SAR 05-07-2025
- Dividend Yield
- HQL 11.56%
- SAR 14.19%
- EPS Growth
- HQL N/A
- SAR 186.33
- EPS
- HQL 0.79
- SAR 2.02
- Revenue
- HQL N/A
- SAR $148,855,238.00
- Revenue This Year
- HQL N/A
- SAR $6.07
- Revenue Next Year
- HQL N/A
- SAR N/A
- P/E Ratio
- HQL $17.08
- SAR $11.59
- Revenue Growth
- HQL N/A
- SAR 3.57
- 52 Week Low
- HQL $11.34
- SAR $21.10
- 52 Week High
- HQL $14.37
- SAR $26.49
- Technical
- Relative Strength Index (RSI)
- HQL 42.81
- SAR 44.44
- Support Level
- HQL $11.88
- SAR $22.22
- Resistance Level
- HQL $13.09
- SAR $25.11
- Average True Range (ATR)
- HQL 0.28
- SAR 0.56
- MACD
- HQL -0.01
- SAR -0.05
- Stochastic Oscillator
- HQL 9.76
- SAR 37.54
About HQL abrdn Life Sciences Investors Shares of Beneficial Interest
abrdn Life Sciences Investors operates as a non-diversified closed-end management investment company. Its investment objective is to seek long-term capital appreciation by investing mostly in securities of Life Sciences companies. It invests in securities of public and private companies that are believed by the Fund's Investment Adviser, abrdn Inc to have potential for above-average growth.
About SAR Saratoga Investment Corp New
Saratoga Investment Corp is a specialty finance company that provides customized financing solutions to U.S. middle-market businesses. The Company invests primarily in senior and unitranche leveraged loans and mezzanine debt, and, to a lesser extent, equity to provide financing for change of ownership transactions, strategic acquisitions, recapitalizations and growth initiatives in partnership with business owners, management teams and financial sponsors. Its objective is to create attractive risk-adjusted returns by generating current income and long-term capital appreciation from its debt and equity investments.